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ABSTRACT
Ribozymes,RNAmoleculesthatcatalyzethecleavage
of RNA substrates, provide an interesting alternative
totheRNAinterference(RNAi)approachtogeneinac-
tivation, especially given the fact that RNAi seems to
trigger an immunological response. Unfortunately,
the limited substrate specificity of ribozymes is con-
sideredtobeasignificanthurdleintheirdevelopment
as molecular tools. Here, we report the molecular
engineering of a ribozyme possessing a new bio-
sensor module that switches the cleavage activity
from‘off’(a‘safetylock’)to‘on’solelyinthepresence
of the appropriate RNA target substrate. Both proof-
of-concept and the mechanism of action of this man-
made riboswitch are demonstrated using hepatitis
delta virus ribozymes that cleave RNA transcripts
derived from the hepatitis B and C viruses. To our
knowledge, this is the first report of a ribozyme bear-
ing a target-dependent module that is activated by its
RNA substrate, an arrangement which greatly dimin-
ishes non-specific effects. This new approach pro-
vides a highly specific and improved tool with
significant potential for application in the fields of
both functional genomics and gene therapy.
INTRODUCTION
The ability of ribozymes (RNA enzymes) to catalyze the
cleavage of RNA substrates makes them attractive potential
molecular tools [reviewed in (1,2)]. Moreover, ribozymes are
an interesting alternative to the RNA interference (RNAi)
approach to gene inactivation as the use of RNAi seems to
trigger an immunological response (3–5). However, the use
of ribozymes in this regard is limited by several factors,
including: delivery problems, effective concentration in vivo
and cellular stability (1,2). In addition, considerable effort has
been directed toward the improvement of substrate speciﬁcity
of ribozymes. For example, the approach of systematic enrich-
ment of ligands by exponential evolution has resulted in the
evolution and selection of allosteric ribozymes, which exhibit
an activity that is both controllable and sensitive (6–13).
Inactive allosteric RNAs are activated by the binding of
effectors that cause conformational transitions yielding active
ribozymes. This is well illustrated by allosteric ribozymes for
which the cleavage activity is regulated by either small bio-
sensor molecules (e.g. ATP) or proteins (e.g. Tat) (8,13).
However, the in vivo potential of allosteric ribozymes
might be limited because they involve a third species (i.e.
the independent effector), which complicates the approach.
Furthermore, the presence of a regulatory module does not
improve the substrate speciﬁcity of these ribozymes in terms
of avoiding the cleavage of an inappropriate target. In other
words, none of these ribozymes is speciﬁcally activated by its
own substrate, which should be considered ideal for greatly
diminishing any non-speciﬁc effects.
With the goal of generating highly speciﬁc ribozymes that
could be regulated by the presence/absence of their target
substrates, we started out with the concept that a ribozyme
should be linked to a target-dependent module that acts as a
biosensor (Figure 1A). In the absence of the target, the
ribozyme should be inactive (‘off’, ‘safety lock’ confor-
mation), while in the presence of the desired substrate the
biosensor should recognize it and activate (turn on) the ribo-
zyme’s cleavage activity. Accordingly, a rational design led to
a ribozyme controlled by a novel speciﬁc on/off adapter
(SOFA). The original delta ribozyme (dRz) derived from
the hepatitis delta virus was used as a suitable model
(14,15). Substrate recognition of this ribozyme is based solely
ontheformationoftheP1stem,whichnecessarilyrequires7bp
(16). The SOFA includes three sequence segments: a blocker,
a biosensor (BS) and a stabilizer (Figure 1B, gray section).
In the absence of the target, the blocker forms an intramole-
cular stem with the P1 strand, resulting in no cleavage.
Upon the addition of the target, the biosensor anneals with
the substrate, thereby releasing the P1 strand so that it can
subsequently hybridize with the substrate and initiating forma-
tion of the active conformation. Thus, the target has two
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doi:10.1093/nar/gki278simultaneous roles: one as an activator and the other as a
substrate. The biosensor acts as a riboswitch regulating the
catalytic activity. This study presents both the proof-of-
concept and the ﬁrst characterization of the molecular mech-
anism of action of this new man-made riboswitch.
MATERIALS AND METHODS
HBV, HCV and ribozyme DNA constructs
The hepatitis B virus (HBV) 1190 nt fragment was excised
from pCHT9/3091 (17) using SacI and EcoRI, and then sub-
cloned into pBlueScript SK, generating pHBV-1190.
The shorter HBV 44 nt substrate was produced using
a PCR-based strategy with T7 sense primer (50-TTA-
ATACGACTCACTATAGGG-30) and antisense primer
(50-CTTCCAAAAGTGAGACAAGAAATGTGAAACCAC-
AAGAGTTGCCCTATAGTGAGTCGTATTAA-30). The
plasmid pHCVA was obtained by cloning the 1348 nt HCV 50
sequence from pHCV-1b (18) into the HindIII/BamHI sites of
pcDNA3(Invitrogen).Theoriginald ribozymeswereconstruc-
ted as described previously (19). SOFA
+/ -ribozymes were
constructed using a PCR-based strategy that included two
complementary and overlapping oligonucleotides. Brieﬂy,
two DNA oligonucleotides were used: the antisense
oligonucleotide [50-CCAGCTAGAAAGGGTCCCTTAG-
CCATCCGCGAACGGATGCCCA(N)6P1ACCGCGAGGA-
GGTGGACCCTG(N)4-BL-30,w h e r eNi sA ,C ,Go rTa n d
BL indicates blocker sequence]; and, the sense primer
[50-TTAATACGACTCACTATAGGGCCAGCTAGTT-
T(N)7–20-BS(N)4-BLCAGGGTCCACC-30]thatpermittedincor-
poration of the T7 RNA promoter. It is important to note that
the (N) segments were varied to correspond to speciﬁc
designed target sequences. The PCR products were puriﬁed
by phenol:chloroform extraction, precipitated with ethanol
and dissolved in water. In vitro transcriptions and puriﬁca-
tions of the ribozymes were then performed as described
below. A similar strategy was used to build the different
versions of ribozyme. All SOFA
 -ribozymes possess the
same biosensor sequence, i.e. 50-GAACATCG GTATCAC-30.
For the in vivo experiments, the open reading frame (ORF)
of the HBV C gene was ampliﬁed from pCH9T/3091 (17)
using two oligonucleotides, a sense (50-TATCTAAAGCTA-
GCTTCATGTCCTACTGTTCAAGCCTCC-30)a n da n
antisense (50-TAGTGAAACTCGAGAATAAAGCCCAGTA-
AAGTTCCCA-30) primer. The PCR product was cloned into
the NheI and XhoI restriction enzyme sites of the pIND
vector (Invitrogen), yielding the pINDHBVC vector. For
the cloning of the ribozymes, we ﬁrst constructed an expres-
sion cassette using two oligonucleotides composed (50!30)
by the KpnI and EcoRV restriction sites followed by a
poly(A) signal. This cassette was subsequently inserted
into HindIII/XhoI-linearized pcDNA3. Second, the PCR pro-
ducts corresponding to the minigenes of the different versions
of the ribozyme described above were reampliﬁed using two
oligonucleotides (sense, 50-ATCCATCGGGTACCGGGC-
CAGTTAGTTT-30; and antisense, 50-CCAGCTAGAAA-
GGGTCCCTTAGCCATCCGCG-30) that permitted the intro-
duction of a KpnI restriction site at the 50 end and also
created a blunt 30 end. The DNA products were then cloned
in KpnI/EcoRV-linearized pcDNA3. The resulting plasmids
were named pmdRz-X, where X represents the cleavage posi-
tion of the ribozyme.
RNA synthesis
Both ribozymes and substrates were synthesized by run-off
transcription from PCR products, HindIII-linearized plasmid
pHBV-1190 and XbaI-linearized plasmid pHCVA templates.
Run-off transcriptions were performed and the resulting tran-
scripts puriﬁed as described previously (19). Subsequently,
the substrates were dephosphorylated and 50 end-labeled with
32P as described previously (19).
Ribozyme cleavage assays
In all reactions, the ribozyme and substrate were preincubated
together at 37 C for 2–5 min, and subsequently magnesium
was added in order to initiate the cleavage. Changing the order
of the addition of the components did not modify the results.
Except when indicated, all reactions were performed under
single turnover conditions ([Rz] > [S]) using 1 mM ribozyme
and trace amounts of either internally
32P-labeled or
32P-50-
end-labeled substrates at 37 C in a ﬁnal volume of 10 ml
containing 50 mM Tris–HCl, pH 7.5 and 10 mM MgCl2.
For the time-course experiments, aliquots (0.8 ml) were
removed at various times up to 3 h and were quenched by
the addition of ice-cold formamide dye buffer (5 mlo f9 7 %
formamide, 10 mM EDTA, pH 8.0), electrophoresed on 6%
PAGE gel and the gels analyzed with a radioanalytic scanner
Figure 1. TheconceptoftheSOFA-ribozyme.(A)Schematicrepresentationof
both the ‘off’ and ‘on’ conformations of the SOFA-ribozyme. The ribozyme
(Rz) and the biosensor (BS) are in blue and red, respectively. The small arrow
indicatesthe cleavagesite.(B) Secondary structureand nucleotidesequenceof
SOFA
+-dRz-303in boththe ‘off’ and the ‘on’conformations. The graysection
indicates the SOFA module. The P1 stem of the ribozyme and the biosensor
are in blue and red, respectively. The blocker sequence is represented in green.
The C76A mutation that produces an inactive ribozyme version is indicated.
The numbering system is according to (15).
Nucleic Acids Research, 2005, Vol. 33, No. 4 1241(PhosphorImager). For the multiple turnover reactions, the
assays were performed at 56 C with an excess of substrate
over ribozyme (10 mM versus 1 mM, respectively). Cleavage
reactions for the mechanism analysis were carried out either
with or without 5 mM of a facilitator (FCO, 50-AAAGTGA-
GACAAGAA-30), biosensor stem (BSO, 50-TTCTTGTC-
TCACTTT-30) and an unrelated (UNO, 50-CCCAATACCA-
CATCA-30) oligodeoxynucleotide. The oligodeoxynuc-
leotides were always mixed, for 5 min at 37 C, ﬁrst with
the RNA component that it bound to, and the reactions then
initiated by the addition of the other RNA component (e.g. the
substrate and FCO were preincubated together, and then the
ribozyme was added to the mixture). Cleavage assays with
the pools of mixed substrates were performed with trace
amounts of radiolabeled substrates (50000 c.p.m.), non-
labeled RNA substrates (2 mM) and SOFA-ribozymes
(500 nM), except in the case of the original ribozyme (WT,
2 mM). The different components were mixed simultaneously,
and the reactions were then incubated for 2 h, analyzed on
denaturing10%PAGEgelsandvisualizedbyPhosphorImager.
Cell culture, DNA transfections and northern blot
hybridization
HEK 293 EcR cells (Human Embryonic Kidney) were grown
in DMEM(Sigma) supplemented with 10% fetal bovineserum
(Wisent) and 0.4 mg/ml of zeocine (Invitrogen) at 37 C under
a humidiﬁed 5% CO2 atmosphere. The cells (2 · 10
5) were co-
transfected with a total of 2 mg of DNA using LipofectAMINE
as per the manufacturer’s instructions (Invitrogen). The pIND-
HBVC and pmdRz-X vectors were present in a ratio of 1:19.
The transfected cells were induced 24 h later by adding ponas-
terone A to a ﬁnal concentration of 1.1 mM, and total RNA
extracted  44 h post-transfection using TriReagent (BioShop
Canada Inc., Burlington). Northern blot analyses of RNA
samples (10 mg) were performed as described previously
(20). The HBV C probe was obtained by cloning the PCR
product of the C gene ampliﬁed above into pBlueScript (SK)
vector in the inverse orientation and then performing run-
off transcription using the T7 RNA polymerase in the presence
of [a-
32P]UTP. The b-actin RNA probe used was prepared
using the Strip-EZ
TM RNA T7/T3 kit (Ambion). All hybrid-
izations were carried out for 16–18 h at 65 C, and the mem-
branes were exposed to PhosphorImager screens for 2–24 h.
RESULTS
Rational design of the SOFA-ribozyme
The molecular engineering of the speciﬁc ‘on/off’ adapter
module followed several steps (Figure 2A). First, a blocker
sequence that forms an intramolecular stem with the catalytic
core of the ribozyme (i.e. the P1 strand region) was added at
the 50 extremity (Figure 2A, lane 3). The resulting molecule
exhibited no cleavage of a small substrate 44 nt in size derived
from the HBV RNA (for sequences, see Materials and
Methods). The blocker acts as a ‘safety lock’ even though
the nucleotide sequences of the d ribozyme portions in both
molecules were identical. Several mutant blocker sequences,
either shorter ones or those producing mismatches, were con-
structed. All exhibited at least a residual cleavage activity,
indicating that mutated blocker sequences do not prevent
completely the ribozyme activity (data not shown). Second,
the ribozyme was further extended at its 50 end by the addition
of a biosensor sequence of 15 nt complementary to the sub-
strate. The resulting construct exhibited a cleavage activity
several times higher than that of the original ribozyme
Figure 2. Rational design and proof-of-concept of the SOFA-ribozyme.
(A) Schematic representation and typical autoradiogram of a denaturing 6%
PAGE gel used to analyze the cleavage reactions of various versions of ribo-
zyme.TheP1stemoftheribozyme(Rz),theblockerandthebiosensor(BS)are
in blue, green and red, respectively. The length of the bands, in nucleotides, is
shown adjacent to the gel. The control ( ) was performed in the absence of
ribozyme(lane1),whilelane2isinthepresenceoftheoriginaldRz.Lanes3–5
areribozymesprogressivelyextendedbytheadditionoftheblocker(lane3),the
biosensor (lane 4) and the stabilizer (lane 5). Lane 6 is a SOFA
 -ribozymethat
consists of a ribozyme harboring an inappropriate biosensor sequence.
(B) Typical autoradiogram of a denaturing 6% PAGE gel used to analyzing
the cleavage reaction of the HBV-derived target by the original- (WT), SOFA-
dRz-303 and -513 ribozymes.The incubation time was 3 h at 37 C. The length
of the bands in nucleotides is shown adjacent to the gel. The control ( ) was
performed in the absence of ribozyme, while SOFA
+ and SOFA
  indicates
SOFA harboring either the appropriate or inappropriate biosensor sequences,
respectively. (C) Graphical representations of time courses for the cleavage
reactions of SOFA
+ (squares), SOFA
  (circles) and the original (inversed
triangles) ribozyme versions of dRz-303 (filled symbols) and dRz-513 (open
symbols). Incubations were performed at 37 C and aliquots were recovered at
0, 2, 5, 10, 15, 20, 40, 60, 120 and 180 min.
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substrate sequence bound by the biosensor was arbitrarily
ﬁxed 5 nt downstream of the last nucleotide participating in
the formation of the P1 stem with the ribozyme. The region
inserted between the P1 stem and the biosensor stem on the
RNA substrate was named the spacer. Third, the ribozyme was
furtherextended atboththe50 and30 endsinordertopermitthe
ends to be joined in a terminal stem (Figure 2A, lane 5). This
last addition was included based on the observations revealing
that the terminal P2 stem of the original d ribozyme provides
an outstanding stability tothisRNA species(21). The presence
of the stabilizer did not inﬂuence the ribozyme’s level of
cleavage. Both the biosensor and the blocker sequences func-
tion independently of the presence/absence of the stabilizer.
Together, the three segments (blocker, biosensor and stabil-
izer) constitute the SOFA module. When the full version of the
SOFA-ribozyme harbors a non-speciﬁc biosensor sequence
(i.e. one unrelated to the substrate), the resulting construct
exhibited no cleavage activity whatsoever (Figure 2A, lane 6).
This SOFA
 -ribozyme remains locked in its inactive con-
formation (‘off’), in contrast to its SOFA
+-ribozyme counter-
part that switched into the ‘on’ conformation.
The SOFA concept is not simply an extension of the com-
plementary sequence. If this was the case, the SOFA
  version
would have to cleave to the same extent as the original
ribozyme, but this is not what is observed. An original feature
of the SOFA is the control of the ribozyme’s activity by the
blocking sequence that acts as a ‘safety lock’ preventing fold-
ing into an active structure, even in the presence of the appro-
priate P1 targeting site on the RNA substrate. Furthermore, the
activation of the SOFA module does not require the presence
of a third species as has been reported for other attempts at
increasing ribozyme speciﬁcity (6,7,10,12,13).
Proof-of-concept of the SOFA-ribozyme
The proof-of-concept of the SOFA-ribozyme was performed
using two accessible sites of the HBV RNA that have previ-
ously been selected for ribozyme cleavage (Rz-303 and
Rz-513; for the sequences see Supplementary Figure 1)
(19). These ribozymes inefﬁciently cleave an HBV-derived
RNA of 1190 nt (Figure 2B,  15%), whereas the correspond-
ing SOFA-ribozymes (SOFA
+) possessing a biosensor exhib-
ited a drastically improved level of cleavage at both sites
( 75%). SOFA
 -ribozymes bearing a biosensor sequence
unrelatedtothe target sequence were foundtobe barely active.
These ribozymes remain locked by the blocker sequence in an
inactive conformation. Time-course experiments reinforced
the conclusion that appending of a speciﬁc SOFA signiﬁcantly
contributed to enhancing the level of cleavage activity
(Figure 2C). Moreover, similar conclusions were reached
for several other SOFA-ribozymes, albeit to different degrees
(data not shown). Variation in the levels of cleavage might be
due to several features, including differences in the binding
efﬁciencies and the rate constants of the SOFA structural
transitions (‘on/off’ conformations).
Characterization of the SOFA-ribozyme
Cleavage activity was investigated using SOFA
+-dRz-303
possessing biosensor sequences of various lengths. Under
single turnover conditions, the cleavage levels increased in
proportion to the size of the biosensor (Figure 3A): the longer
thebase-paired segment,thebetterthe bindingoftheribozyme
to the substrate and the higher level of cleavage. Kinetic ana-
lyses permitted the determination of second order rate con-
stants (Table 1, kcat/KM). The ribozymes SOFA
+-dRz-303-
BS10 and -BS15 had kcat/KM values of 1.5 · 10
5 min
 1
M
 1 and 2.3 · 10
5 min
 1 M
 1, respectively. These values
are 16- and 25-fold higher than that of the original ribozyme
(i.e. 9.3 · 10
3 min
 1 M
 1). These improvements are due to
smaller KM and higher kcat values (3- and 8-fold each, respect-
ively), probably representing a better formation of the active
ribozyme–substrate complex that results in less dissociation
and more cleavage. Either single or double mutations in the
biosensor sequence of SOFA
+-dRz-303-BS10, which pro-
duces a mismatch between the substrate and the ribozyme,
were sufﬁcient to cause a 25-fold reduction in the kcat/KM
value (Supplementary Figure 2). The ribozyme SOFA
 -
dRz-303-BS10 had a kcat/KM value 2239 times smaller than
that of its active counterpart. This observation is in good
agreement with the idea that the blocker sequence acts to
efﬁciently prevent the adoption of the active structure.
Under multiple turnover conditions, a smaller HBV-derived
substrate was used, since the length of the latter affects the
Figure 3. Characterization of SOFA
+-dRz-303. (A) Autoradiogram of a
denaturing 6% PAGE gel showing the cleavage assays of the HBV-derived
substrate by SOFA
+-dRz-303 bearing biosensor stems of various lengths
(BS-X,whereXindicatesthelengthofthestem).Thereactionswereperformed
under single turnover conditions at 37 C for 3 h. (B) Autoradiogram of a 20%
PAGEgelshowingthecleavageassaysofthe44ntHBV-derivedsubstratebya
SOFA
+-dRz-303 bearing a biosensor stem of various lengths. The reactions
were performed at 37 C for 2 h under multiple turnover conditions. XC
indicates the position of the xylene cyanol dye. For (A) and (B), the length
of the bands in nucleotides is shown adjacent to the gel. The control ( ) was
performed in the absence of ribozyme.
Table 1. Kinetic analysis of various versions of SOFA-dRz-303 under single
turnover conditions
Ribozymes kcat (min
 1) KM (nM) kcat/Km
(min
 1 M
 1)
dRz-303 0.007 – 0.001 750 – 100 9.3 · 10
3
SOFA
+-dRz-303-BS15 0.053 ± 0.008 226 – 30 2.3 · 10
5
SOFA
 -dRz-303-BS15 0.00008 – 0.00002 600 – 150 1.3 · 10
2
SOFA
+-dRz-303-BS10 0.023 – 0.003 150 – 20 1.5 · 10
5
SOFA
 -dRz-303-BS10 0.00004 – 0.00001 600 – 150 6.7 · 10
1
Nucleic Acids Research, 2005, Vol. 33, No. 4 1243turnover rate of the ribozyme (22). In this case, the level of
cleavage increased in proportion to the length of the biosensor,
up to 10 bp, at which point it decreased with increasing length
(Figure 3B). Elongation of the biosensor stimulates the cleav-
age activity up to the point where, most probably, product
release becomes rate limiting. Interestingly, in this speciﬁc
experiment, the SOFA
+-dRz-303-BS-10 performed four turn-
overs (i.e. since the concentration ofsubstrate is10-fold higher
than that of the ribozyme, the cleavage of 40% substrate cor-
responds to four turnovers), while the original ribozyme com-
pletedonlyone.Theobservationofseveralturnoversindicated
that the product release is not the rate-limiting step for the
SOFA-ribozyme. A SOFA-ribozyme in which the cytosine in
position 76 was mutated to adenosine was also synthesized
(Figure 1B, SOFA
+-dRzC76A-303). This mutation yields
a SOFA
 -ribozyme that exhibited the same binding ability,
but is completely devoid of any of cleavage activity (data not
shown). This result demonstrates that the biosensor is not
directly implicated in the cleavage reaction; rather, it acts
as a facilitator resulting in an increased level of cleavage.
More importantly, the SOFA-ribozyme meets the classical
criteria of an enzyme (e.g. it exhibits turnover) (23).
Overview of the molecular mechanism of
a SOFA-ribozyme
The mechanism of action of both the biosensor and blocker
sequences was investigated using an oligonucleotide competi-
tion approach coupled with mutated ribozymes (Figure 4). The
addition of an oligonucleotide possessing the same sequence
as the biosensor (FCO) slightly increased the level of cleavage
of the original Rz-303. This oligonucleotide acts as a facilit-
ator that renders the binding site more accessible to the cata-
lytic region of the ribozyme (24,25). In contrast, the presence
of the FCO did not alter the level of cleavage of SOFA
+-dRz-
303 after 3 h of incubation; whereas, it required more time to
reach the same cleavage level (data not shown). One possib-
ility is that the binding of both the biosensor and the P1
sequence favorably competes with the FCO for the substrate.
When the experiment was repeated using an oligonucleotide
complementary to the biosensor sequence (BSO), the cleavage
activity of the SOFA
+-ribozyme was drastically decreased.
Conversely, the presence of an oligonucleotide having an
unrelated sequence (UNO) did not modify the cleavage
level. Finally, the contribution of the blocker sequence was
assessed using SOFA
 -dRz-303. This ‘off’-version, which
lacks the appropriate biosensor, but possesses the appropriate
P1 stem, barely demonstrated a detectable level of cleavage.In
contrast, a mutant lacking the blocker sequence exhibited a
higher cleavage activity than did the SOFA
 -ribozyme.
Hence, the blocker plays its role by preventing the formation
ofthe P1steminthe absence of the appropriatebiosensor. This
requirement increases the speciﬁcity of the SOFA because it
can only be activated by the desired substrate. Thus, the bind-
ing of the biosensor to the substrate is the ﬁrst step as there
is no cleavage activity if the biosensor stays in the locked
conformation.
Improved substrate specificity
The speciﬁcity of a ribozyme can commonly be deﬁned by
its ability to discriminate between similar RNA substrates
(23). In order to illustrate the gain in terms of substrate
speciﬁcity, two distinct experiments were performed. First,
10 substrates were designed, each possessing an identical
P1 binding sequence coupled to a completely different
biosensor binding sequence. The substrates were successively
extended at their 50 ends by at least 2 nt in order to provide
them with different electrophoretic mobilities (Figure 5A).
When all of the substrates were incubated together with a
given SOFA
+-ribozyme, only the substrate harboring the rel-
evant requirements, in terms of sequence recognition by the
biosensorofthatparticularribozyme,wascleaved(Figure5B).
The lower cleavage levels observed for substrates ‘b’ and ‘j’
were indicative of the inﬂuence of the biosensor’s sequence
identity. This experiment reveals that a ribozyme, activated by
the proper substrate, does not cleave other substrates via a
trans-cleavage mechanism. Conversely, the original ribozyme
did not make this discrimination (lane WT), and all substrates
were cleaved, although at different levels. This study shows
the advantage of the ‘safety lock’ concept. Any non-speciﬁc
cleavage was observed for the SOFA-ribozyme as compared
with the original ribozyme results. Kinetic experiments were
performed using an excess of ribozyme, thereby permitting
determination of kobs that are near the kcat. Overall, the kobs of
the SOFA-ribozymes cleaving the perfectly complementary
substrates were at least three orders of magnitude higher
than that of the other substrates (data not shown). Thus,
each ribozymecut efﬁcientlyonlyitsperfectly complementary
substrate.
Figure 4. Analysis of the mechanism of action of the SOFA-d ribozyme. The
upperpanelshowstheproposedsequentialinteractionsbetweenthedRzandthe
substrate. The roman numerals identify the steps of the mechanism. Dashed
linesindicateoligonucleotidebindingtoeitherthesubstrate(i.e.FCOactingas
facilitator) orthe biosensor(BSO).The lowerpanel is a histogramshowingthe
relative cleavage efficiencies as calculated from two independent sets of
experiments using the original- (WT), SOFA
+- and SOFA
 -dRz-303
ribozymes incubated either with or without the FCO, BSO and unrelated
(UNO) oligonucleotides.
1244 Nucleic Acids Research, 2005, Vol. 33, No. 4In a second experiment, we attempted to selectively cleave
sitesoflongRNA moleculesthatincludedidentical P1binding
sequences, but different biosensor sequences. A sequence 7 nt
long was found to be present twice in the HBV fragment
(Figure 6A and B, i.e. cleavage at positions 398 and 993).
In addition, the classical dRzs did not permit the detection
of cleavage at either of these sites, most likely because they
were embedded in complex structures. This result is in agree-
ment with a previous study that showed that these regions of
HBV were inaccessible to ribozyme cleavage via three differ-
ent protocols (19). In contrast, SOFA-d ribozymes exhibited
anefﬁcient andspeciﬁc cleavage atthesesites(i.e.withoutany
interference between the sites). This corroborates the power of
the SOFA module, and points out that it enables the cleavage
of a substrate uncleavable by the original ribozyme. Similar
results were obtained when targeting a repeated sequence (i.e.
the cleavage sites at positions 224 and 302) within the highly
structured internal ribosome entry site (IRES) of the HCV
(26,27). The wild-type ribozyme cleaved the HCV-derived
transcripts at both sites (positions 224 and 302), although
inefﬁciently. The SOFA
+ versions produced a good level of
speciﬁc cleavage (Figure 6C and D). More importantly, the
position of the cleavages was dictated by the identity of the
biosensor sequences. This implies that no cis-cleavage was
Figure 5. Trans-cleavage analysis of various SOFA-d ribozymes.
(A) Schematic representation of the HBV target substrates. All the
ribozymes and substrates have a similar P1 stem sequences (in blue), but
differ in their biosensor sequences (in various colors). The small arrow
indicates the cleavage site (for the sequences, see Supplementary Table 1).
(B) Cleavage assays of a pool of ten 50 end-labeled substrates (a–j) by either a
specific SOFA-d ribozyme (named A–J), or the original ribozyme (WT). The
reactionswereperformedat37 Cfor3h.BPBandXCindicatethepositionsof
the bromophenol blue and xylene cyanol dyes, respectively. The control ( )
was performed in the absence of ribozyme.
Figure 6. Cis-cleavage analysis of various SOFA-d ribozymes. (A and C)
Schematic representation of the HBV and HCV target substrates,
respectively. For these experiments, the sequence of the P1 stem is identical
ateach site,butthebiosensorsequencesaredifferent(see thelegendontheleft
of the Figure). (B) Autoradiogram of the cleavage assays of the 1190 nt HBV-
derivedtargetbySOFA-ribozymescleavingateitherposition398or993.Lane1
is the control performed in the absence of ribozyme. Lane 2 is the reaction
performedinthepresenceoftheoriginaldRzthatcleavesatbothsites(positions
398 and 993). Lanes 3 and 4 are the reactions performed with the SOFA
+-dRz-
398and 993ribozymes,respectively.Finally,lane5isthereactionperformed
in the presence of both the SOFA
+-dRz-398 and -993. The reactions were
performed at 37 C for 3 h. (D) Autoradiogram of the cleavage assays of a
1422 nt HCV-derived target by SOFA-d ribozymes cleaving at either position
224 or 302 of the IRES. Lane 1 is the control performed in the absence of
ribozyme. Lane 2 is the reaction performed in the presence of the original dRz
thatcleavesatbothsites(positions224and302).Lanes3and4arethereactions
performedwiththeSOFA
+-dRz-224and-302ribozymes,respectively.Finally,
lane 5 is the reaction performed in the presence of both the SOFA
+-dRz-224
and -302. The reactions were performed at 37 C for 3 h. All of the target site
sequences of these substrates are presented in Supplementary Figure 1. The
expected cleavage fragments are shown with their corresponding sizes in nt.
Nucleic Acids Research, 2005, Vol. 33, No. 4 1245observed in these studies. Clearly, these experiments establish
the high substrate speciﬁcity of the SOFA module, in addition
to illustrating its character as a facilitator (i.e. unwinding the
secondary structure in the neighborhood of the target site).
Thus, the accessibility of target sites became a lesser hurdle
than is for classical ribozymes (20).
Activity of SOFA-ribozymes in cellular environment
In order to demonstrate the potential of SOFA-ribozymes as
molecular tools for gene-inactivation systems, a preliminary
experiment targeting an HBV-derived transcript was per-
formed in cell culture (Figure 7). First, the ORF of the
HBV C gene was cloned into the inducible pIND vector
(Figure 7A, upper part). Using HEK-293 EcR cells, which
stably express the ecdysone receptor thereby permitting the
inductor ponasterone A to enter the cell, it is possible to con-
trol the expression of the target RNA species. Second, several
ribozymes were cloned downstream of the cytomegalovirus
(CMV) promoter of a modiﬁed version of the pcDNA3 vector
(Figure 7A, lower part; see also Materials and Methods). This
modiﬁed version should permit the in vivo transcription by
RNA polymerase II, and ensure localization of the ribozymes
in the cytoplasm. Both vectors were co-transfected, and the
expressionoftheHBVtranscriptsinduced.Thecellswere then
harvested and the RNA extracted and analyzed by northern
blot hybridization. Figure 7B shows a typical autoradiogram.
In the presence of SOFA
+-dRz-303, an  50% reduction in the
level of HBV C gene was observed (compare lanes 1 and 2).
This is a reduction of several folds due to the presence of the
SOFA
+-dRz-303, as comparedwiththe corresponding original
ribozyme (data not shown). Conversely, no signiﬁcant reduc-
tion was observed in the presence of SOFA
+-dRzC76A-303
(<2%), an inactive mutant which is the ideal control for the
presence of any antisense effect (20). Similarly, no decrease
was observed in the presence of either SOFA
 -dRz-303 or
SOFA
 -dRzC76A-303 (Figure 7B, lanes 3 and 4), illustrating
the necessity of the appropriate biosensor for a ribozyme to be
active, and supporting the ‘safety lock’ role played by the
blocker sequence. Together, these data conﬁrm the great
potential of the target-dependent module for signiﬁcantly
improving ribozyme speciﬁcity in a cellular environment.
DISCUSSION
The concept of a target-dependent module provides for a new
generation of biosensorized ribozymes possessing signiﬁc-
antly improved substrate speciﬁcities and efﬁciencies. The
‘on’ conformation implies that a ribozyme with a greater afﬁn-
ity for its substrate subsequently cleaves them faster. Mean-
while, the ‘off’ conformation prevents the cleavage of an
inappropriate target, acting as a ‘safety lock’. The design of
the speciﬁc ‘on/off’ adapter was inﬂuenced by several factors.
First, it is reminiscent of the human immune system, specif-
ically the cytotoxic T lymphocyte’s activation mechanism
(28). The T lymphocytes bind speciﬁc cell surface molecules,
which in turn dictate the T cell’s responses (i.e. binding activ-
ates the T cells which in turn kill the target cell). In the same
way, the SOFA-ribozyme hybridizes to the RNA target (the
activator) and speciﬁcally cleaves it. Second, the biosensor’s
mechanism is reminiscent of that of an oligonucleotide acting
as facilitator for ribozyme cleavage (24,25). However, the
linkage of the biosensor directly to the ribozyme permitted
a signiﬁcant gain, in terms of cleavage activity, as compared
with the use of two distinct molecules. As the activation is
mediated by the substrate, this might constitute an important
advantage for further use in a cellular environment because it
implies that these are no limitations in terms of timing and
localization for any additional components. Third, the blocker
stem was inﬂuenced by the TRAP strategy (for targeted
ribozyme-attenuated probe), in which a 30 terminal attenuator
anneals to conserved bases in the catalytic core to form the
‘off’ state of a hammerhead ribozyme (7). The blocker
sequence of the SOFA module also inactivates the cleavage
activity of the ribozyme by binding a sequence that is part of
the catalytic core. Finally, the idea of a stabilizer stem that
places the 30 end of the SOFA module in a double-stranded
region originated from the previous demonstration that the P2
stem of the dRz, which plays the same role in the wild-type
ribozyme, provides an outstanding stability to this RNA spe-
cies (21). However, it is important to note that the biosensor
and blocker sequences function independently of the presence
of the stabilizer domain. A version of the SOFA-ribozyme
lacking the stabilizer sequence cleaved the HBV transcripts
to the same extent as the original version (Figure 2A). Clearly,
the SOFA module is the fruit of a rational design. Using the
SELEX approach, it would have been impossible to develop
this kind of module for a ribozyme.
Figure 7. Activity of SOFA-ribozymes in a cellular environment. (A) Sche-
matic representation of the expression vectors for both the HBV C target gene
(upperpart)andtheribozymes(lowerpart).(B)Autoradiogramofnorthernblot
hybridization. The transfection control was performed using pmdRz devoid of
any ribozyme gene (lane 1). Lanes 2 and 3 are RNA samples extracted from
HEK-293 EcR cultured cells expressing SOFA
+-dRz-303 and SOFA
+-
dRzC76A-303, respectively. Lanes 3 and 4 are RNA samples extracted from
cultured cells expressing SOFA
 -dRz-303 and SOFA
 -dRzC76A-303Rz,
respectively. b-actin was used as a control for normalizing the results. The
databelowtheautoradiogramcorrespondtothepercentageofreductionoftheC
mRNA as compared with the control lane 1. Note that two independent sets
of data were used to determine average values.
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anisms: the ‘safety lock’ action of the blocker sequence and
the activation of the ribozyme. Brieﬂy, the SOFA module
enables the ribozyme to only cleave the desired target
sequence. Even with the presence of an appropriate P1
stem sequence in the substrate, if the sequence complementary
tothebiosensorisabsent,nocleavagewasobserved(Figure5).
The ribozyme is blocked in an ‘off’ conformation by the
blocker. Consequently, all tested SOFA
 -ribozymes (i.e.
those possessing an unrelated biosensor, but a good P1
ribozyme sequence) were representative of the ‘off’conforma-
tion (e.g. Figures 2, 4, 5 and 7, ‘safety lock’). In other words,
the ribozyme is always in an inactive conformation, except if
the biosensor is triggered. A biosensor has to bind its com-
plementary sequence in order to unlock a SOFA module,
thereby permitting the folding of the catalytic core into an
‘on’ conformation. The action of the biosensor constitutes
the second crucial mechanism associated with the SOFA
action. Both the blocker and the biosensor contribute to the
increased substrate speciﬁcity of the ribozyme’s cleavage,
although differently. Overall the presence of the biosensor
increased the kcat/KM values at least one order of magnitude
over that of the original ribozyme (see Table 1). In the case of
the blocker, which affects the basal level of activity, we
observed a decrease in the kcat/KM value of a SOFA
 -
ribozyme of two orders of magnitude (i.e. probably up to
three orders of magnitude according to the kobs analyses
for many other tested ribozymes) (L. J. Bergeron and
J. P. Perreault, unpublished data). The latter effect is the
most important one in terms of numbers because it contributes
to the prevention of the cleavage of erroneous substrates.
Together, the blocker and the biosensor of the SOFA concept
have lead to the designing of efﬁcient ribozymes that turnover
and possess an improved substrate speciﬁcity.
The important gain in terms of substrate speciﬁcity was
illustrated by several experiments. The experiment performed
with the pool of 10 substrates having similar P1 stem
sequences, but different complementary sequences for bio-
sensor binding, showed that a SOFA
+-ribozyme cleaved
only the appropriate substrate without interference from the
other substrates via a trans-cleavage mechanism (Figure 5).
Moreover, this experiment showed that, even in the presence
of the appropriate cleavage site on each substrate, the blocker
mechanism permits the ribozyme to stay in the ‘off’ conforma-
tion until it is activated by the proper substrate. This was not
the case with the original ribozyme that cleaved all substrates,
although at different levels. The same conclusions were
reached from the targeting of similar cis-cleavage sequences
harboring different binding sequences forthe biosensor inboth
the HBV and HCV transcripts (Figure 6). In this case, the
ribozymes exhibited cleavage at the site proximal to the bio-
sensors, but never to that of the distal site. This shows that the
distance between the cleavage site and the binding sequence of
the biosensor on a substrate is important. In this regard, further
characterization should establish the optimal distance between
the biosensor and the cleavage site.
The SOFA-module provides the ribozyme with improved
substrate speciﬁcity. However, is this sufﬁcient to target only
one RNA species in a cellular environment? Considering only
the base pairs formed during the two binding steps between an
optimal SOFA-d ribozyme and its substrate (7 bp for P1 stem
binding + 10 bp for the biosensor stem), this means that 1 site
should exist per 1.7 · 10
10 bases (4
17). Since the human gen-
ome is composed of 3 · 10
9bp, of which only  5% constitutes
mRNA (i.e. 1.5 · 10
8 bases), this is more than sufﬁcient to feel
secure in terms of substrate speciﬁcity. However, this is true
only if all nucleotides contribute fully to the speciﬁcity, mean-
ing that no mismatches can be tolerated, which is not neces-
sarily the case. Some experiments have to be performed in
order to address this question. Although the probability of
ﬁnding two sites appears to be negligible, if it does occur
the SOFA-ribozyme will distinguish between the two. Other
features also contribute favorably to the speciﬁcity. For
example, the nucleotides 50 of the cleavage site have been
shown to contribute as an external determinant that deﬁnes
the ability of a substrate to be cleaved (29,30).
Here, we have includedinitial datashowingthe inhibitionof
the expression of the HBV C gene. In this example, the expres-
sion of the SOFA-ribozymes was under the control of a poly-
merase II promoter (CMV) present in a pcDNA3 derived
vector. It is interesting to note that a catalyst exhibiting a
(biologically speaking) relatively short rate constant (see
Figure 2B, half-life near 15 min) has a signiﬁcant effect on
the steady-state level of a target mRNA (Figure 7B, near
50% reduction in HBV C mRNA). Implicit in this data is
the issue that target mRNA half-life is an important consid-
eration or limitation, as only mRNAs with relatively long half-
lives (>30 min) would be expected to be signiﬁcantly down-
regulated by such catalysts. However, selection of more active
ribozymes will allow targeting of a wide range of mRNA
targets. Other attempts at investigating the potential use of
the SOFA-ribozyme as RNA molecular tools are currently
underway. These experiments include use of various targets
(i.e. endogenous mRNAs and viral RNAs), different
approaches, such as RNA transfection and the generation of
stably transfected cells for the production of the SOFA-
ribozyme, as well as in several biological systems, such as
prokaryotes and eukaryotes. Other research perspectives
involve characterizing in intimate detail all features of the
SOFA module, as well as the kinetics of its mechanism of
action. Additionally, it will be of interest to verify whether or
not the concept of the SOFA module offers some ﬂexibility in
itsdesign.Forexample, theSOFA modulewasalsointroduced
within the L4 loop (Figure 1B; data not shown). The
blocker sequence of this later SOFA-module interacted with
the sequence of the J4/2 junction of the ribozyme. The SOFA
+
version exhibited a relatively high cleavage activity, while
the SOFA
  did not cleave the substrate. Clearly, this indicates
that the SOFA module is malleable and can be easily adapted,
since its function is based on the simple and rational hybrid-
ization potential of component parts.
To our knowledge, this is the ﬁrst report of a ribozyme of
an endonuclease-type that harbors a ‘safety lock’ target-
dependent module that is activated by an RNA substrate
and subsequently cleaves this molecule. More speciﬁcally,
this new ribozyme concept is a single molecule, which can
be considered as a clear advantage over other technologies
(e.g. allosteric ribozymes). Finally, this new approach pro-
vides an improved tool with signiﬁcant potential in both func-
tional genomics and gene therapy. Furthermore, this concept
can be substantially extended to other RNA drug-based
molecules.
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